Vendor
5 FDA submission entries in this directory. This is not a count of distinct commercial offers.
Claim vendor profileEach entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.
Prepare with a buyer guide:
Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families
Neurophet., Inc.
Authorized purpose: Brain MRI/PET registration, segmentation and quantitative PET assessment
Neurophet., Inc.
Authorized purpose: Neurophet AQUA is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from a set of MR images; volumetric data may be compared to reference percentile data.
Neurophet., Inc.
Authorized purpose: Quantitative brain MRI and amyloid-PET analysis, including volumetric reference-percentile comparison and SUVR quantification, to support physician clinical evaluation.
Neurophet, Inc.
Authorized purpose: Neurophet AQUA is intended for Automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images. Volumetric data may be compared to reference percentile data.
NEUROPHET, Inc.
Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures from MR images, with optional comparison of volumetric data to reference percentile data; a support tool for structural-MRI assessment.